Viewing Study NCT06719661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2026-02-05 @ 11:58 AM
Study NCT ID: NCT06719661
Status: COMPLETED
Last Update Posted: 2025-06-05
First Post: 2024-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.
Sponsor: University of Sulaimani
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus (T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Uncontrolled type 2 diabetes View
None Dapagliflozin View
None Effects on HbA1c View
None Effects on body weight View
None Effects on fasting plasma glucose level View